Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.
Content
Multiple Myeloma
12m 6s
Double or Triple hit lymphoma : implications for clinicians
Published 11 Jul 2022
Double or triple-hit B-cell lymphomas (DHL and THL) are rare lymphomas associated with poor prognosis. Defining features of DHL & THL are two or three recurrent chromosome translocations namely MYC and bcl-2 gene or/and BCL6 chromosomal translocation. Determination of cell of origin by IHC is practised before proceeding with FISH test. DHL & THL have aggressive presentation and high-risk CNS involvement and hence CNS prophylaxis can be considered for these patients.
